Physician
Jing, Tong
Jing, Tong was paid $4.61M by Medicaid between Mar 2018 and Dec 2024, across 24 billing codes. Its largest line is 43239, Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple — 21% of everything it billed.
33Billing provider infoJING, TONG
FLUSHING, NY 11354
FLUSHING, NY 11354
33aNPI1316916778assigned 03/16/2006
33bProvider typeGastroenterology Physician
28Total paid$4.61M
24GClaims48,871
24DCodes billed24
24AFirst – last monthMar 2018 – Dec 2024
Compared with peers
Next to other Gastroenterology Physician providers in New York
Rank by total paid#12 of 656
Median peer was paid$12K
This provider vs. median378×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 945 | $115K | |
| 2019 | 3,459 | $359K | |
| 2020 | 4,281 | $410K | |
| 2021 | 9,702 | $811K | |
| 2022 | 10,419 | $979K | |
| 2023 | 10,738 | $1.05M | |
| 2024incomplete | 9,327 | $878K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 21% | 3,024 | 3,009 | $969K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 13,282 | 8,719 | $913K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 16% | 1,950 | 1,923 | $731K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 12% | 4,015 | 3,996 | $569K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 12% | 2,869 | 2,337 | $568K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 5.1% | 4,397 | 3,571 | $233K |
| 88312 | 4.1% | 1,570 | 1,565 | $189K | |
| 88313 | 3.3% | 2,858 | 2,332 | $154K | |
| 99402 | 2.1% | 2,643 | 2,630 | $97K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 2,077 | 1,740 | $84K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 462 | 404 | $23K |
| 88342 | <1% | 427 | 425 | $18K |
12 more codes
| 36000 | <1% | 3,253 | $11K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 554 | $11K |
| 99051 | <1% | 2,746 | $9K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 79 | $9K |
| 88341 | <1% | 129 | $7K | |
| 99223 | Prolong inpt eval add15 m | <1% | 136 | $3K |
| 83013 | <1% | 49 | $3K | |
| 99072 | <1% | 1,593 | $743.31 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 19 | $670.32 |
| A4550 | Surgical trays | <1% | 677 | $517.50 |
| 91200 | <1% | 13 | $458.08 | |
| 83014 | <1% | 49 | $326.09 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.